ad

4120 友華生技醫藥

本益成長比: N/A  總報酬本益比: N/A  合理價格(本益比法): N/A  合理價格(ROE法): N/A
友華生技醫藥
  • EPS 年複合成長率: N/A% (109-105)
  • 營業利益年複合成長率: N/A% (109-105)
  • 本益比: N/A
  • 近四季EPS總合: -0.94 (-0.54,-0.08,0.07,-0.39)
  • 融資餘額佔股本比例:0.82%
  • 融資使用率: 3.26%
  • 近期收盤價: 32.2 (2022-01-25)

股價漲跌幅

202220212020
友華生技醫藥-6.0%-23.0%-13.0%
0050-3.24%50.48%14.17%


營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近5年

20202019201820172016
營業毛利率44.9946.1946.8347.2246.12
營業利益率2.195.526.458.339.05
折舊負擔比率3.252.641.851.782.05
稅前淨利率4.645.996.7110.198.92
股東權益報酬率2.773.443.588.4510.51
資產報酬率1.632.072.315.376.65
本業收入比47.2092.0595.9581.61101.50
業外獲益比52.807.953.7818.20-1.50
無形資產佔淨值比1.271.581.190.000.00




營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業毛利率44.2345.6144.2241.6043.0946.4648.0345.65
營業利益率-3.60-7.711.67-8.55-6.887.4013.652.18
折舊負擔比率3.603.713.463.263.683.272.842.62
稅前淨利率-3.95-4.97-0.07-1.74-2.8810.2410.895.56
股東權益報酬率-1.62-0.47-0.27-1.97-0.842.842.77-0.15
資產報酬率-0.56-0.14-0.04-0.89-0.341.461.430.00
本業收入比91.11155.36-2000.00491.30235.2971.74125.4439.33
業外獲益比8.89-55.362100.00-391.30-138.2427.54-25.4460.67
無形資產佔淨值比1.101.181.231.271.361.401.491.58




現金流量-近5年 (1.避開近3年累計小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)

20202019201820172016
營運現金流量(百萬)609227231600111
自由現金流量(百萬)2412734345-272
稅後淨利(百萬)199248247459470




現金流量-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營運現金流量(百萬)6532-223174-4240198-71
自由現金流量(百萬)-268-352-32871-12423460-114
稅後淨利(百萬)-47-76-34-1312811833




成長能力-近5年 (營業利益和稅後淨利成長率要大於營業收入成長率)

20202019201820172016
營業收入(百萬)53846093551052265232
營業利益(百萬)118336355435474
稅後淨利(百萬)199248247459470
EPS(完全稀釋)2.292.842.835.275.38
營業收入成長率(%)-11.6410.585.43-0.116.62
營業利益成長率(%)-64.88-5.35-18.39-8.2379.55
稅後淨利成長率(%)-19.760.40-46.19-2.34110.76
EPS成長率(%)-19.370.35-46.30-2.04110.16




成長能力-近4季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業收入(百萬)11401131121513211168134515501602
營業利益(百萬)-41-8720-113-809921235
稅後淨利(百萬)-47-76-34-1312811833
EPS(完全稀釋)-0.54-0.080.07-0.39-0.151.481.360.38
去年同期營業收入成長率(%)-2.40-15.91-21.61-17.54----
去年同期營業利益成長率(%)48.75-187.88-90.57-422.86----
去年同期稅後淨利成長率(%)-261.54-105.47-94.92-203.03----
去年同期EPS成長率(%)-260.00-105.41-94.85-202.63----
較上季營業收入成長率(%)0.80-6.91-8.0213.10-13.16-13.23-3.25-
較上季營業利益成長率(%)52.87-535.00117.70-41.25-180.81-53.30505.71-
較上季稅後淨利成長率(%)-571.43-216.67117.65-161.54-110.168.47257.58-
較上季EPS成長率(%)-575.00-214.29117.95-160.00-110.148.82257.89-




每月營收變化

年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2021/12-15.38-19.08-11.45
2021/115.240.9-10.7
2021/1010.4312.0-11.89
2021/9-0.91-17.51-14.17
2021/814.144.43-13.73
2021/7-16.2612.71-15.89

稅前淨利較去年同期

2021Q3(百萬)2020Q3(百萬)YoY(%)
-45.0-34.0-32.35
2021Q2(百萬)2020Q2(百萬)YoY(%)
-56.0138.0-140.5
2021Q1(百萬)2020Q1(百萬)YoY(%)
-1.0169.0-100.5

EPS較上季

2021Q3(元)2021Q2(元)比率
-0.54-0.08-5.75

應收帳周轉率和存貨周轉率-近5年

20202019201820172016
應收帳款周轉率8.778.317.577.397.67
存貨周轉率2.152.592.682.562.97




應收帳周轉率和存貨周轉率-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
應收帳款周轉率1.921.972.222.562.142.072.182.18
存貨周轉率0.550.490.520.580.510.570.600.64




償債能力-近5年

20202019201820172016
負債比0.520.520.430.380.40
金融負債(百萬)2142190414309541174
營業收入淨額(百萬)53846093551052265232
利息保障倍數9.2715.6523.4631.6929.19
長期銀行借款占稅後淨利比3.812.492.930.811.63




償債能力-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
負債比0.610.580.520.520.500.520.510.52
金融負債(百萬)34903032244821422040206820921904
營業收入淨額(百萬)11401131121513211168134515501602
利息保障倍數-3.63-6.500.91-2.10-3.4419.2522.9513.42
長期銀行借款占稅後淨利比119.50119.50119.505.745.745.745.9618.70




成本指標-近5年

20202019201820172016
營業收入淨額(百萬)53846093551052265232
推銷費用(百萬)11951337117210941032
管理費用(百萬)743752661560544
研究發展費(百萬)367395389379363
推銷費用率(%)22.2021.9421.2720.9319.72
管理費用率(%)13.8012.3412.0010.7210.40
研究發展費用率(%)6.826.487.067.256.94




成本指標-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業收入淨額(百萬)11401131121513211168134515501602
推銷費用(百萬)283316285334302276283361
管理費用(百萬)172184160187190183183219
研究發展費(百萬)9010372144906668122
推銷費用率(%)24.8227.9423.4625.2825.8620.5218.2622.53
管理費用率(%)15.0916.2713.1714.1616.2713.6111.8113.67
研究發展費用率(%)7.899.115.9310.907.714.914.397.62




財務健檢燈號

上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
OXOXOOOXXX
19年8.67億47.81%61.41%0.0%213.84%48百萬-6.48%

融資使用率

日期股價融資使用率
2022-01-2532.23.26%
2022-01-2432.83.27%
2022-01-2133.23.29%
2022-01-2033.653.30%
2022-01-1933.153.45%
2022-01-1833.43.46%
2022-01-1733.653.51%
2022-01-1434.03.50%
2022-01-1334.23.86%
2022-01-1234.13.86%
2022-01-1134.33.86%
2022-01-1035.054.37%
2022-01-0734.954.34%
2022-01-0635.74.33%
2022-01-0535.94.36%
2022-01-0436.054.37%
2022-01-0336.254.37%
2021-12-3036.354.40%
2021-12-2936.24.45%
2021-12-2836.54.42%
2021-12-2736.454.40%
2021-12-2436.04.38%
2021-12-2336.24.61%
2021-12-2236.254.61%
2021-12-2136.04.61%
2021-12-2036.14.61%
2021-12-1736.354.60%
2021-12-1636.34.60%
2021-12-1536.14.62%
2021-12-1436.254.62%
2021-12-1336.854.70%
2021-12-1037.54.74%
2021-12-0937.64.76%
2021-12-0838.04.75%
2021-12-0738.34.71%
2021-12-0638.84.71%
2021-12-0338.354.63%
2021-12-0238.64.61%
2021-12-0138.954.61%
2021-11-3038.54.61%
2021-11-2938.64.60%
2021-11-2639.154.62%
2021-11-2539.54.67%
2021-11-2438.94.68%
2021-11-2338.754.68%
2021-11-2238.94.66%
2021-11-1939.04.65%
2021-11-1839.054.64%
2021-11-1739.254.61%
2021-11-1639.54.60%
2021-11-1539.654.59%
2021-11-1239.44.59%
2021-11-1139.54.58%
2021-11-1039.654.59%
2021-11-0939.654.58%
2021-11-0840.054.62%
2021-11-0540.24.61%
2021-11-0440.34.59%
2021-11-0340.954.57%
2021-11-0241.154.56%
2021-11-0142.354.55%
2021-10-2940.84.58%
2021-10-2841.054.57%
2021-10-2740.554.56%
2021-10-2639.754.56%
2021-10-2540.154.56%
2021-10-2240.04.56%
2021-10-2139.94.56%
2021-10-2040.154.55%
2021-10-1940.954.54%
2021-10-1841.14.55%
2021-10-1540.454.51%
2021-10-1439.84.51%
2021-10-1339.44.51%
2021-10-1239.554.51%
2021-10-0840.64.51%
2021-10-0740.054.51%
2021-10-0640.34.53%
2021-10-0539.44.53%
2021-10-0438.74.54%
2021-10-0138.94.57%
2021-09-3039.254.57%
2021-09-2939.24.57%
2021-09-2839.554.58%
2021-09-2739.24.59%
2021-09-2439.34.60%
2021-09-2339.24.59%
2021-09-2239.24.59%
2021-09-1739.154.59%
2021-09-1639.34.59%



沒有留言:

張貼留言